A double−blind, placebo−controlled crossover trial to quantify the effects of sibutramine on energy intake and energy expenditure in obese subjects during a test meal

Femme Homme

| Pays :
| Organes :
| Spécialités :

Extrait

To evaluate the effects of sibutramine (at two dose levels of 10 and 15 mgs) against placebo control in terms of food intake using a computerized eating monitor.

Critère d'inclusion

Obesity defined as BMI > 30 kg /m2

Liens

ictrp
euctr